SEC Form 4 · accession 0001144204-18-013977
ASSEMBLY BIOSCIENCES, INC. · ASMB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Helen Susan Kim
Director
Period of report
Mar 8, 2018
Accepted (ET)
Mar 12, 2018 · 7:26 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001426800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $57.53 | Mar 8, 2018 | A | 20,000 | A | — | Mar 8, 2028 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The shares of common stock underlying the option will vest in equal annual installments on the first, second and third anniversaries of the grant date.